News
Novo Holdings acquires global CDMO in billion dollar all-cash transaction
![Sagsomtale - Novo køber Catalent.png](/files/styles/landscape_kr_01/public/media/image/Sagsomtale%20-%20Novo%20k%C3%B8ber%20Catalent.png?h=669ad1bb&itok=v4ce7Exe)
We are pleased to have assisted Novo Holdings A/S, the investment company of the Novo Nordisk Foundation, as Danish legal counsel in relation to its entry into a merger agreement under which it will acquire Catalent (NYSE: CTLT) in an all-cash transaction valuing Catalent at USD 16.5 billion.
As part of the transaction, Novo Holdings will carve-out and sell three fill-finish sites located in Italy, Belgium and the USA to its affiliate Novo Nordisk A/S.
See further details on the transactions on the Novo Holdings website and the Novo Nordisk website.
Practice areas
Industries
Contact
![Christian Lundgren](/files/styles/landscape_kr_01/public/persons/CL.jpg?h=d1cb525d&itok=YW_viNl9)
Partner (Copenhagen)
Dir. +45 38 77 45 30
Mob. +45 40 74 37 75
![Jakob Hans Johansen](/files/styles/landscape_kr_01/public/persons/JAJ.jpg?h=d1cb525d&itok=XgPanhuP)
Partner (Copenhagen)
Dir. +45 38 77 44 20
Mob. +45 61 61 30 32